Vir Biotechnology (VIR) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $8.8 million.
- Vir Biotechnology's Accumulated Depreciation & Amortization fell 2476.66% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year decrease of 2476.66%. This contributed to the annual value of $14.6 million for FY2024, which is 2515.04% down from last year.
- Vir Biotechnology's Accumulated Depreciation & Amortization amounted to $8.8 million in Q3 2025, which was down 2476.66% from $5.8 million recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Accumulated Depreciation & Amortization ranged from a high of $19.5 million in Q4 2023 and a low of $1.5 million during Q2 2022
- Its 5-year average for Accumulated Depreciation & Amortization is $9.2 million, with a median of $8.8 million in 2025.
- In the last 5 years, Vir Biotechnology's Accumulated Depreciation & Amortization tumbled by 8779.19% in 2022 and then skyrocketed by 83575.0% in 2023.
- Quarter analysis of 5 years shows Vir Biotechnology's Accumulated Depreciation & Amortization stood at $5.3 million in 2021, then increased by 27.98% to $6.8 million in 2022, then surged by 186.76% to $19.5 million in 2023, then dropped by 25.15% to $14.6 million in 2024, then plummeted by 39.68% to $8.8 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $8.8 million for Q3 2025, versus $5.8 million for Q2 2025 and $2.9 million for Q1 2025.